XML 21 R8.htm IDEA: XBRL DOCUMENT
v3.24.3

Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2024
Segment Reporting [Abstract] |
Segment Information | 2. Segment Information In the fourth quarter of 2023, MetLife reorganized from five segments into the following six segments to reflect changes in management’s responsibilities: Group Benefits, RIS, Asia, Latin America, EMEA and MetLife Holdings. The Group Benefits and RIS businesses were previously reported as the U.S. segment. These changes were applied retrospectively and did not have an impact on prior period total consolidated net income (loss) or adjusted earnings. In addition, the Company continues to report certain of its results of operations in Corporate & Other. Group Benefits The Group Benefits segment, based in the U.S., offers a broad range of products to corporations and their respective employees, other institutions and their respective members, as well as individuals. These products include term, variable and universal life insurance, dental, group and individual disability, vision and accident & health insurance. RIS The RIS segment, based in the U.S., offers a broad range of life and annuity-based insurance and investment products to corporations and their respective employees, other institutions and their respective members, as well as individuals. These products include stable value and pension risk transfer products, institutional income annuities, structured settlements, longevity reinsurance solutions, benefit funding solutions and capital markets investment products. Asia The Asia segment offers a broad range of products and services to both individuals and corporations, as well as to other institutions, and their respective employees, which include life insurance, accident & health insurance and retirement and savings. Latin America The Latin America segment offers a broad range of products to both individuals and corporations, as well as to other institutions, and their respective employees, which include life insurance, retirement and savings, accident & health insurance and credit insurance. EMEA The EMEA segment offers products to individuals, corporations, other institutions, and their respective employees, which include life insurance, retirement and savings, accident & health insurance and credit insurance. MetLife Holdings The MetLife Holdings segment consists of operations relating to products and businesses that the Company no longer actively markets in the U.S. These include variable, universal, term and whole life insurance, variable, fixed and index-linked annuities and long-term care insurance. It also includes an in-force block of assumed variable annuity guarantees from a third party. Corporate & Other Corporate & Other contains various start-up, developing and run-off businesses. Also included in Corporate & Other are: the excess capital, as well as certain charges and activities, not allocated to the segments (including external integration and disposition costs, internal resource costs for associates committed to acquisitions and dispositions and enterprise-wide strategic initiatives), interest expense related to the majority of the Company’s outstanding debt, expenses associated with certain legal proceedings and income tax audit issues, the elimination of intersegment amounts (which generally relate to investment expenses and intersegment loans bearing interest rates commensurate with related borrowings), and the Company’s investment management business (through which the Company provides public fixed income, private capital and real estate investment solutions to institutional investors worldwide). Financial Measures and Segment Accounting Policies Adjusted earnings is used by management to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, adjusted earnings is also the Company’s GAAP measure of segment performance and is reported below. Adjusted earnings should not be viewed as a substitute for net income (loss). The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Adjusted earnings is defined as adjusted revenues less adjusted expenses, net of income tax. These financial measures focus on the Company’s primary businesses principally by excluding the impact of (i) market volatility which could distort trends, (ii) asymmetrical and non-economic accounting, and (iii) revenues and costs related to divested businesses, non-core products and certain entities required to be consolidated under GAAP. Also, these measures exclude results of discontinued operations under GAAP. Market volatility can have a significant impact on the Company’s financial results. Adjusted earnings excludes net investment gains (losses), net derivative gains (losses), market risk benefits (“MRBs”) remeasurement gains (losses) and goodwill impairments. Further, policyholder benefits and claims exclude (i) changes in the discount rate on certain annuitization guarantees accounted for as additional liabilities, and (ii) market value adjustments. Asymmetrical and non-economic accounting adjustments are made to the line items indicated in calculating adjusted earnings: •Net investment income includes earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment. •Other revenues include settlements of foreign currency earnings hedges and exclude asymmetrical accounting associated with in-force reinsurance. •Policyholder benefits and claims excludes (i) amortization of basis adjustments associated with de-designated fair value hedges of future policy benefits (“FPBs”), (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments, (iii) asymmetrical accounting associated with in-force reinsurance, and (iv) non-economic losses incurred at contract inception for certain single premium annuity business. These losses are amortized into adjusted earnings within policyholder benefits and claims over the estimated lives of the contracts. •Interest credited to policyholder account balances (“PABs”) excludes amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass-through adjustments and asymmetrical accounting associated with in-force reinsurance. Divested businesses are those that have been or will be sold or exited by MetLife but do not meet the discontinued operations criteria under GAAP. Divested businesses also include the net impact of transactions with exited businesses that have been eliminated in consolidation under GAAP and costs relating to businesses that have been or will be sold or exited by MetLife that do not meet the criteria to be included in results of discontinued operations under GAAP. Other adjustments are made to the line items indicated in calculating adjusted earnings: •Net investment income and interest credited to PABs excludes certain amounts related to contractholder-directed equity securities. •Other revenues include fee revenue on synthetic guaranteed interest contracts (“GICs”) accounted for as freestanding derivatives. •Other revenues exclude and other expenses include fees received in connection with services provided under transition service agreements. •Other expenses exclude (i) implementation of new insurance regulatory requirements and other costs, and (ii) acquisition, integration and other related costs. Other expenses include (i) deductions for net income attributable to noncontrolling interests, and (ii) benefits accrued on synthetic GICs accounted for as freestanding derivatives. Adjusted earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance. The tax impact of the adjustments mentioned above are calculated net of the U.S. or foreign statutory tax rate, which could differ from the Company’s effective tax rate. Additionally, the provision for income tax (expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms. Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the three months and nine months ended September 30, 2024 and 2023. The segment accounting policies are the same as those used to prepare the Company’s interim condensed consolidated financial statements, except for adjusted earnings adjustments as defined above. In addition, segment accounting policies include the method of capital allocation described below. Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model accounts for the unique and specific nature of the risks inherent in the Company’s business. The Company’s economic capital model, coupled with considerations of local capital requirements, aligns segment allocated equity with emerging standards and consistent risk principles. The model applies statistics-based risk evaluation principles to the material risks to which the Company is exposed. These consistent risk principles include calibrating required economic capital shock factors to a specific confidence level and time horizon while applying an industry standard method for the inclusion of diversification benefits among risk types. The Company’s management is responsible for the ongoing production and enhancement of the economic capital model and reviews its approach periodically to ensure that it remains consistent with emerging industry practice standards. Segment net investment income is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact the Company’s consolidated net investment income, net income (loss) or adjusted earnings. Net investment income is based upon the actual results of each segment’s specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company’s product pricing.
Three Months Ended September 30, 2024 |  | Group Benefits |  | RIS |  | Asia |  | Latin America |  | EMEA |  | MetLife Holdings |  | Corporate & Other |  | Total |  | Adjustments |  | Total Consolidated
|  | (In millions)
Revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Premiums |  | $ | 5,538 |  |  | $ | 1,451 |  |  | $ | 1,272 |  |  | $ | 1,141 |  |  | $ | 562 |  |  | $ | 673 |  |  | $ | (6) |  |  | $ | 10,631 |  |  | $ | 16 |  |  | $ | 10,647 |
Universal life and investment-type product policy fees |  | 231 |  |  | 67 |  |  | 420 |  |  | 346 |  |  | 84 |  |  | 80 |  |  | — |  |  | 1,228 |  |  | — |  |  | 1,228 |
Net investment income |  | 311 |  |  | 2,133 |  |  | 1,132 |  |  | 435 |  |  | 55 |  |  | 981 |  |  | 96 |  |  | 5,143 |  |  | 84 |  |  | 5,227 |
Other revenues |  | 377 |  |  | 61 |  |  | 18 |  |  | 9 |  |  | 9 |  |  | 40 |  |  | 98 |  |  | 612 |  |  | 36 |  |  | 648 |
Net investment gains (losses) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (77) |  |  | (77) |
Net derivative gains (losses) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 767 |  |  | 767 |
Total revenues |  | 6,457 |  |  | 3,712 |  |  | 2,842 |  |  | 1,931 |  |  | 710 |  |  | 1,774 |  |  | 188 |  |  | 17,614 |  |  | 826 |  |  | 18,440 |
Expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Policyholder benefits and claims and policyholder dividends |  | 4,927 |  |  | 2,247 |  |  | 1,035 |  |  | 1,091 |  |  | 276 |  |  | 1,221 |  |  | — |  |  | 10,797 |  |  | (50) |  |  | 10,747 |
Policyholder liability remeasurement (gains) losses |  | — |  |  | (148) |  |  | 60 |  |  | (18) |  |  | 9 |  |  | (35) |  |  | — |  |  | (132) |  |  | — |  |  | (132) |
MRB remeasurement (gains) losses |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 531 |  |  | 531 |
Interest credited to PABs |  | 49 |  |  | 874 |  |  | 683 |  |  | 108 |  |  | 17 |  |  | 84 |  |  | — |  |  | 1,815 |  |  | 222 |  |  | 2,037 |
Capitalization of deferred policy acquisition costs (“DAC”) |  | (4) |  |  | (53) |  |  | (336) |  |  | (174) |  |  | (119) |  |  | (4) |  |  | (1) |  |  | (691) |  |  | — |  |  | (691) |
Amortization of DAC and value of business acquired (“VOBA”) |  | 6 |  |  | 14 |  |  | 217 |  |  | 126 |  |  | 92 |  |  | 58 |  |  | 3 |  |  | 516 |  |  | — |  |  | 516 |
Amortization of negative VOBA |  | — |  |  | — |  |  | (6) |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | (7) |  |  | — |  |  | (7) |
Interest expense on debt |  | — |  |  | 4 |  |  | — |  |  | 4 |  |  | — |  |  | 4 |  |  | 245 |  |  | 257 |  |  | — |  |  | 257 |
Other expenses |  | 1,007 |  |  | 183 |  |  | 758 |  |  | 485 |  |  | 342 |  |  | 220 |  |  | 164 |  |  | 3,159 |  |  | 29 |  |  | 3,188 |
Total expenses |  | 5,985 |  |  | 3,121 |  |  | 2,411 |  |  | 1,622 |  |  | 616 |  |  | 1,548 |  |  | 411 |  |  | 15,714 |  |  | 732 |  |  | 16,446 |
Provision for income tax expense (benefit) |  | 99 |  |  | 119 |  |  | 125 |  |  | 88 |  |  | 24 |  |  | 44 |  |  | (41) |  |  | 458 |  |  | 195 |  |  | 653 |
Adjusted earnings |  | $ | 373 |  |  | $ | 472 |  |  | $ | 306 |  |  | $ | 221 |  |  | $ | 70 |  |  | $ | 182 |  |  | $ | (182) |  |  | 1,442 |  |  |  |  |
Adjustments to: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 826 |  |  |  |  |
Total expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (732) |  |  |  |  |
Provision for income tax (expense) benefit |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (195) |  |  |  |  |
Net income (loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 1,341 |  |  |  |  | $ | 1,341 |
Three Months Ended September 30, 2023 |  | Group Benefits |  | RIS |  | Asia |  | Latin America |  | EMEA |  | MetLife Holdings |  | Corporate & Other |  | Total |  | Adjustments |  | Total Consolidated
|  | (In millions)
Revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Premiums |  | $ | 5,276 |  |  | $ | 2,330 |  |  | $ | 1,312 |  |  | $ | 1,116 |  |  | $ | 502 |  |  | $ | 685 |  |  | $ | 9 |  |  | $ | 11,230 |  |  | $ | — |  |  | $ | 11,230 |
Universal life and investment-type product policy fees |  | 219 |  |  | 82 |  |  | 411 |  |  | 359 |  |  | 79 |  |  | 184 |  |  | — |  |  | 1,334 |  |  | — |  |  | 1,334 |
Net investment income |  | 330 |  |  | 2,009 |  |  | 1,023 |  |  | 365 |  |  | 51 |  |  | 1,153 |  |  | 125 |  |  | 5,056 |  |  | (231) |  |  | 4,825 |
Other revenues |  | 371 |  |  | 66 |  |  | 20 |  |  | 9 |  |  | 7 |  |  | 41 |  |  | 103 |  |  | 617 |  |  | (11) |  |  | 606 |
Net investment gains (losses) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (927) |  |  | (927) |
Net derivative gains (losses) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,202) |  |  | (1,202) |
Total revenues |  | 6,196 |  |  | 4,487 |  |  | 2,766 |  |  | 1,849 |  |  | 639 |  |  | 2,063 |  |  | 237 |  |  | 18,237 |  |  | (2,371) |  |  | 15,866 |
Expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Policyholder benefits and claims and policyholder dividends |  | 4,592 |  |  | 3,100 |  |  | 1,095 |  |  | 1,020 |  |  | 230 |  |  | 1,311 |  |  | 4 |  |  | 11,352 |  |  | (69) |  |  | 11,283 |
Policyholder liability remeasurement (gains) losses |  | (29) |  |  | (76) |  |  | 108 |  |  | (4) |  |  | (9) |  |  | (7) |  |  | — |  |  | (17) |  |  | — |  |  | (17) |
MRB remeasurement (gains) losses |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (796) |  |  | (796) |
Interest credited to PABs |  | 50 |  |  | 756 |  |  | 576 |  |  | 106 |  |  | 19 |  |  | 198 |  |  | — |  |  | 1,705 |  |  | (47) |  |  | 1,658 |
Capitalization of DAC |  | (5) |  |  | (41) |  |  | (404) |  |  | (171) |  |  | (114) |  |  | (5) |  |  | (2) |  |  | (742) |  |  | — |  |  | (742) |
Amortization of DAC and VOBA |  | 6 |  |  | 13 |  |  | 204 |  |  | 121 |  |  | 87 |  |  | 65 |  |  | 3 |  |  | 499 |  |  | — |  |  | 499 |
Amortization of negative VOBA |  | — |  |  | — |  |  | (6) |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | (7) |  |  | — |  |  | (7) |
Interest expense on debt |  | — |  |  | 3 |  |  | — |  |  | 2 |  |  | — |  |  | 4 |  |  | 256 |  |  | 265 |  |  | — |  |  | 265 |
Other expenses |  | 937 |  |  | 138 |  |  | 788 |  |  | 493 |  |  | 315 |  |  | 238 |  |  | 250 |  |  | 3,159 |  |  | 30 |  |  | 3,189 |
Total expenses |  | 5,551 |  |  | 3,893 |  |  | 2,361 |  |  | 1,567 |  |  | 527 |  |  | 1,804 |  |  | 511 |  |  | 16,214 |  |  | (882) |  |  | 15,332 |
Provision for income tax expense (benefit) |  | 135 |  |  | 124 |  |  | 130 |  |  | 83 |  |  | 24 |  |  | 51 |  |  | (79) |  |  | 468 |  |  | (429) |  |  | 39 |
Adjusted earnings |  | $ | 510 |  |  | $ | 470 |  |  | $ | 275 |  |  | $ | 199 |  |  | $ | 88 |  |  | $ | 208 |  |  | $ | (195) |  |  | 1,555 |  |  |  |  |
Adjustments to: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2,371) |  |  |  |  |
Total expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 882 |  |  |  |  |
Provision for income tax (expense) benefit |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 429 |  |  |  |  |
Net income (loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 495 |  |  |  |  | $ | 495 |
Nine Months Ended September 30, 2024 |  | Group Benefits |  | RIS |  | Asia |  | Latin America |  | EMEA |  | MetLife Holdings |  | Corporate & Other |  | Total |  | Adjustments |  | Total Consolidated
|  | (In millions)
Revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Premiums |  | $ | 16,848 |  |  | $ | 4,574 |  |  | $ | 3,785 |  |  | $ | 3,378 |  |  | $ | 1,634 |  |  | $ | 2,078 |  |  | $ | 15 |  |  | $ | 32,312 |  |  | $ | 16 |  |  | $ | 32,328 |
Universal life and investment-type product policy fees |  | 682 |  |  | 215 |  |  | 1,280 |  |  | 1,089 |  |  | 238 |  |  | 252 |  |  | 1 |  |  | 3,757 |  |  | — |  |  | 3,757 |
Net investment income |  | 939 |  |  | 6,339 |  |  | 3,407 |  |  | 1,219 |  |  | 163 |  |  | 3,007 |  |  | 297 |  |  | 15,371 |  |  | 497 |  |  | 15,868 |
Other revenues |  | 1,156 |  |  | 185 |  |  | 57 |  |  | 31 |  |  | 24 |  |  | 127 |  |  | 293 |  |  | 1,873 |  |  | 87 |  |  | 1,960 |
Net investment gains (losses) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (873) |  |  | (873) |
Net derivative gains (losses) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (720) |  |  | (720) |
Total revenues |  | 19,625 |  |  | 11,313 |  |  | 8,529 |  |  | 5,717 |  |  | 2,059 |  |  | 5,464 |  |  | 606 |  |  | 53,313 |  |  | (993) |  |  | 52,320 |
Expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Policyholder benefits and claims and policyholder dividends |  | 14,943 |  |  | 6,966 |  |  | 3,090 |  |  | 3,092 |  |  | 799 |  |  | 3,724 |  |  | 17 |  |  | 32,631 |  |  | (30) |  |  | 32,601 |
Policyholder liability remeasurement (gains) losses |  | (1) |  |  | (170) |  |  | 24 |  |  | (29) |  |  | 10 |  |  | 2 |  |  | — |  |  | (164) |  |  | — |  |  | (164) |
MRB remeasurement (gains) losses |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (345) |  |  | (345) |
Interest credited to PABs |  | 145 |  |  | 2,508 |  |  | 1,987 |  |  | 337 |  |  | 53 |  |  | 293 |  |  | — |  |  | 5,323 |  |  | 1,004 |  |  | 6,327 |
Capitalization of DAC |  | (13) |  |  | (160) |  |  | (1,032) |  |  | (527) |  |  | (362) |  |  | (13) |  |  | (7) |  |  | (2,114) |  |  | — |  |  | (2,114) |
Amortization of DAC and VOBA |  | 19 |  |  | 45 |  |  | 634 |  |  | 380 |  |  | 265 |  |  | 174 |  |  | 6 |  |  | 1,523 |  |  | — |  |  | 1,523 |
Amortization of negative VOBA |  | — |  |  | — |  |  | (16) |  |  | — |  |  | (3) |  |  | — |  |  | — |  |  | (19) |  |  | — |  |  | (19) |
Interest expense on debt |  | 1 |  |  | 11 |  |  | — |  |  | 11 |  |  | — |  |  | 11 |  |  | 744 |  |  | 778 |  |  | — |  |  | 778 |
Other expenses |  | 3,026 |  |  | 500 |  |  | 2,204 |  |  | 1,502 |  |  | 1,002 |  |  | 663 |  |  | 546 |  |  | 9,443 |  |  | 49 |  |  | 9,492 |
Total expenses |  | 18,120 |  |  | 9,700 |  |  | 6,891 |  |  | 4,766 |  |  | 1,764 |  |  | 4,854 |  |  | 1,306 |  |  | 47,401 |  |  | 678 |  |  | 48,079 |
Provision for income tax expense (benefit) |  | 315 |  |  | 332 |  |  | 460 |  |  | 271 |  |  | 71 |  |  | 116 |  |  | (158) |  |  | 1,407 |  |  | (335) |  |  | 1,072 |
Adjusted earnings |  | $ | 1,190 |  |  | $ | 1,281 |  |  | $ | 1,178 |  |  | $ | 680 |  |  | $ | 224 |  |  | $ | 494 |  |  | $ | (542) |  |  | 4,505 |  |  |  |  |
Adjustments to: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (993) |  |  |  |  |
Total expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (678) |  |  |  |  |
Provision for income tax (expense) benefit |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 335 |  |  |  |  |
Net income (loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 3,169 |  |  |  |  | $ | 3,169 |
Nine Months Ended September 30, 2023 |  | Group Benefits |  | RIS |  | Asia |  | Latin America |  | EMEA |  | MetLife Holdings |  | Corporate & Other |  | Total |  | Adjustments |  | Total Consolidated
|  | (In millions)
Revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Premiums |  | $ | 16,154 |  |  | $ | 5,512 |  |  | $ | 3,999 |  |  | $ | 3,164 |  |  | $ | 1,497 |  |  | $ | 2,127 |  |  | $ | 44 |  |  | $ | 32,497 |  |  | $ | — |  |  | $ | 32,497 |
Universal life and investment-type product policy fees |  | 660 |  |  | 232 |  |  | 1,204 |  |  | 1,046 |  |  | 231 |  |  | 537 |  |  | 1 |  |  | 3,911 |  |  | — |  |  | 3,911 |
Net investment income |  | 967 |  |  | 5,771 |  |  | 2,954 |  |  | 1,162 |  |  | 143 |  |  | 3,450 |  |  | 255 |  |  | 14,702 |  |  | (160) |  |  | 14,542 |
Other revenues |  | 1,114 |  |  | 205 |  |  | 61 |  |  | 31 |  |  | 23 |  |  | 143 |  |  | 310 |  |  | 1,887 |  |  | (21) |  |  | 1,866 |
Net investment gains (losses) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2,650) |  |  | (2,650) |
Net derivative gains (losses) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2,289) |  |  | (2,289) |
Total revenues |  | 18,895 |  |  | 11,720 |  |  | 8,218 |  |  | 5,403 |  |  | 1,894 |  |  | 6,257 |  |  | 610 |  |  | 52,997 |  |  | (5,120) |  |  | 47,877 |
Expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Policyholder benefits and claims and policyholder dividends |  | 14,452 |  |  | 7,766 |  |  | 3,282 |  |  | 2,962 |  |  | 728 |  |  | 4,021 |  |  | 32 |  |  | 33,243 |  |  | 31 |  |  | 33,274 |
Policyholder liability remeasurement (gains) losses |  | (31) |  |  | (116) |  |  | 92 |  |  | (5) |  |  | (10) |  |  | 28 |  |  | — |  |  | (42) |  |  | — |  |  | (42) |
MRB remeasurement (gains) losses |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,425) |  |  | (1,425) |
Interest credited to PABs |  | 144 |  |  | 2,104 |  |  | 1,682 |  |  | 310 |  |  | 54 |  |  | 595 |  |  | — |  |  | 4,889 |  |  | 566 |  |  | 5,455 |
Capitalization of DAC |  | (16) |  |  | (136) |  |  | (1,202) |  |  | (470) |  |  | (341) |  |  | (17) |  |  | (7) |  |  | (2,189) |  |  | — |  |  | (2,189) |
Amortization of DAC and VOBA |  | 19 |  |  | 36 |  |  | 587 |  |  | 344 |  |  | 257 |  |  | 197 |  |  | 8 |  |  | 1,448 |  |  | — |  |  | 1,448 |
Amortization of negative VOBA |  | — |  |  | — |  |  | (17) |  |  | — |  |  | (3) |  |  | — |  |  | — |  |  | (20) |  |  | — |  |  | (20) |
Interest expense on debt |  | 1 |  |  | 10 |  |  | — |  |  | 8 |  |  | — |  |  | 10 |  |  | 747 |  |  | 776 |  |  | — |  |  | 776 |
Other expenses |  | 2,819 |  |  | 430 |  |  | 2,373 |  |  | 1,388 |  |  | 929 |  |  | 707 |  |  | 656 |  |  | 9,302 |  |  | 77 |  |  | 9,379 |
Total expenses |  | 17,388 |  |  | 10,094 |  |  | 6,797 |  |  | 4,537 |  |  | 1,614 |  |  | 5,541 |  |  | 1,436 |  |  | 47,407 |  |  | (751) |  |  | 46,656 |
Provision for income tax expense (benefit) |  | 318 |  |  | 339 |  |  | 435 |  |  | 233 |  |  | 62 |  |  | 139 |  |  | (265) |  |  | 1,261 |  |  | (1,028) |  |  | 233 |
Adjusted earnings |  | $ | 1,189 |  |  | $ | 1,287 |  |  | $ | 986 |  |  | $ | 633 |  |  | $ | 218 |  |  | $ | 577 |  |  | $ | (561) |  |  | 4,329 |  |  |  |  |
Adjustments to: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (5,120) |  |  |  |  |
Total expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 751 |  |  |  |  |
Provision for income tax (expense) benefit |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,028 |  |  |  |  |
Net income (loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 988 |  |  |  |  | $ | 988 |
The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:
|  | September 30, 2024 |  | December 31, 2023
|  | (In millions)
Group Benefits |  | $ | 36,894 |  |  | $ | 36,715 |
RIS |  | 229,709 |  |  | 218,587 |
Asia |  | 162,531 |  |  | 157,206 |
Latin America |  | 73,419 |  |  | 69,177 |
EMEA |  | 19,653 |  |  | 18,596 |
MetLife Holdings |  | 146,403 |  |  | 148,524 |
Corporate & Other |  | 36,367 |  |  | 38,779 |
Total |  | $ | 704,976 |  |  | $ | 687,584 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 9: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration